Report for: Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial

Title	Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial
Published in	Trials, April 2021
DOI	10.1186/s13063-021-05282-w
Pubmed ID	33910617
Authors	Naoki Hosogaya, Taiga Miyazaki, Yuri Fukushige, Sachiko Takemori, Shinpei Morimoto, Hiroshi Yamamoto, Makoto Hori, Tomoya Kurokawa, Yohei Kawasaki, Michiko Hanawa, Yasuhisa Fujii, Hideki Hanaoka, Shingo Iwami, Koichi Watashi, Satoshi Yamagoe, Yoshitsugu Miyazaki, Takaji Wakita, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae, Shigeru Kohno

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
France	1	100%

Type	Count	As %
Members of the public	1	100%

Mendeley readers

The data shown below were compiled from readership statistics for 211 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	211	100%

Readers by professional status	Count	As %
Student > Bachelor	26	12%
Student > Master	23	11%
Other	13	6%
Researcher	10	5%
Student > Ph. D. Student	8	4%
Other	32	15%
Unknown	99	47%

Readers by discipline	Count	As %
Medicine and Dentistry	49	23%
Nursing and Health Professions	18	9%
Biochemistry, Genetics and Molecular Biology	8	4%
Pharmacology, Toxicology and Pharmaceutical Science	4	2%
Unspecified	4	2%
Other	25	12%
Unknown	103	49%

Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial